+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Norvasc"

Investigation Report on China's Amlodipine Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Amlodipine Market, 2018-2022

  • Report
  • December 2018
  • 30 Pages
  • China
From
Norvasc - API Insight, 2022 - Product Thumbnail Image

Norvasc - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Norvasc- Drug Insight, 2019 - Product Thumbnail Image

Norvasc- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Norvasc is a calcium channel blocker used to treat hypertension and angina. It is a popular drug in the cardiovascular drug market, as it is effective in reducing blood pressure and relieving chest pain. Norvasc is also used to treat coronary artery disease, and can be used in combination with other drugs to treat congestive heart failure. It is generally well-tolerated, with few side effects. Norvasc is available in both generic and brand-name forms, and is widely prescribed by doctors. It is available in tablet form, and can be taken once or twice daily. The cardiovascular drug market is highly competitive, with many different drugs available to treat various conditions. Norvasc is one of the most popular drugs in this market, due to its effectiveness and low side effects. Some companies in the Norvasc market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more